Results 171 to 180 of about 28,141,875 (293)

Comparative efficacy of GLP‐1 RA, tirzepatide and SGLT‐2 inhibitors in metabolic liver disease: A network meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aim Metabolic liver disease, including nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis, is a major cause of chronic liver dysfunction worldwide, creating an urgent need for effective treatments. This systematic literature review (SLR) and network meta‐analysis (NMA) systematically reviews and compares the efficacy and safety ...
Andrej Belančić, Christina Antza, Anastasios Poutachidis, Smaro Palaska, Elvira Meni Maria Gkrinia, Andrea Katrin Faour, Yusuf Ziya Sener, Seher Sener, Rehena Sultana   +8 more
wiley   +1 more source

Potentially Inappropriate Medication Use in Older Adults in Primary Care According to Four Explicit Criteria: Associations with Patient Factors. [PDF]

Medicina (Kaunas)
Paraschiv M, Vasincu A, Rusu RN, Gavril OI, Trandabăț BA, Ciobîcă A, Bild V.   +6 more
europepmc   +1 more source

Trend in Prevalence and Distribution of Diabetes Mellitus Type I and Type II in the Netherlands [PDF]

Value in Health, 2014
Overbeek, J.A., Penning, F.J.A., van Dongen, E., Herings, R.M.C.   +3 more
openaire   +2 more sources

Exposure‐adjusted safety and efficacy of GLP‐I and GLP‐1/GIP receptor agonists compared with non‐GLP‐I for weight management and type 2 diabetes: Based on FDA medical and statistical reports of 34 280 safety and 36 312 efficacy subjects

British Journal of Clinical Pharmacology, EarlyView.
Aims This work aimed to contextualize glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and glucose‐dependent insulinotropic polypeptide (GIP) receptor agonists safety and efficacy regarding weight management (WM); we analysed Food and Drug Administration (FDA) Medical Reviews to analyse 14 medications using patient‐exposure year normalization and ...
Aishwarya Prasad, Anshu Arora, Arun Arora, Jeena Vaid, Arif Khan   +4 more
wiley   +1 more source

Chronic obstructive pulmonary disease and diabetes mellitus: a bidirectional meta-analysis of risk and comorbidity burden. [PDF]

Front Endocrinol (Lausanne)
He S, Karunakaran M, Rushender R, Hariharan VS.   +3 more
europepmc   +1 more source

A CASE REPORT ON THE AYURVEDIC MANAGEMENT OF DIABETES MELLITUS TYPE I.

ABSTRACT Prameha in Ayurveda can be correlated with Diabetes Mellitus (DM). DM is a metabolic disorder characterized by high blood glucose level & associated with other manifestations. ‘Diabetes’ means ‘polyuria’ and ‘mellitus’ means ‘honey’. In Ayurveda, it is a tridosha vyadhi but mainly Kapha Pradhan & meda, mansa, kleda, rakta, vasa, majja, lasika,
openaire   +1 more source

British National Formulary Guidance on prescribing in pregnancy: A descriptive cross‐sectional study

British Journal of Clinical Pharmacology, EarlyView.
Aim To assess how well pregnancy‐specific guidance within the British National Formulary supports healthcare professionals to facilitate safe and effective medication use. Methods We performed a manifest content analysis of the text of all pregnancy sections within British National Formulary drug monographs, with inductive and iterative coding.
Hannah Johnson, Cleodie Swire, Lakshiv Dhingra, Toqa El‐Nahhas, Michelle Essiam, Salma Muse, Maria Tonkova, Nazmin Begum, Joan Morris, Emma Baker   +9 more
wiley   +1 more source

Implication of Sulfatide in Type 1 Diabetes and Multiple Sclerosis. Comment on Root-Bernstein, R. Type 1 Diabetes-Associated Autoantibodies, Sera and T-Cell Receptor Sequences Recognize Myelin Basic Protein: A Novel Peripheral Diabetic Neuropathy-Multiple Sclerosis Connection. <i>Cells</i> 2026, <i>15</i>, 1384. [PDF]

Cells
Thea R, Buschard K.
europepmc   +1 more source

Ceftriaxone‐induced liver injury: Incidence, phenotypic characterization and predictive factors

British Journal of Clinical Pharmacology, EarlyView.
Introduction Ceftriaxone is a widely used third‐generation cephalosporin in hospitalized patients. Although generally considered safe, it has been associated with hepatobiliary complications and emerging reports of drug‐induced liver injury (DILI). However, data on its true incidence, phenotypic patterns, and predictors remain limited. This study aimed
Mohamed Hatem, Mohannad N. AbuHaweeleh, Humam Emad Rajha, Mhd Osama Rahhal, Ahmad Hamdan, Lina Naseralallah   +5 more
wiley   +1 more source

Risk factors for post-traumatic lymphedema after open fractures of the lower leg: a retrospective cohort study. [PDF]

Front Surg
Huang X, Zhang Y, Lv Z, Liu Z, Dong S, Zhou R, Ju W, Ju J, Hou R.   +8 more
europepmc   +1 more source